“…Trials under way include the search for medications already established for treatment of other conditions that may be repurposed for treatment of ALS ( Mehta et al, 2021 ). Mg 2+ therapies have been reported in previous experimental studies and clinical trials focused on mitigation of OP toxicity ( Bradley, 1986 ; Basher et al, 2013 ; Philomena et al, 2016 ; Vijayakumar et al, 2017 ; Jamshidi et al, 2018 ). The potential efficacy of magnesium has been considered previously in the context of nutrition or treatment of patients with ALS but clinical data from studies of MgSO 4 in both contexts have not been decisive ( Longnecker et al, 2000 ; Pamphlett et al, 2003 ; Fondell et al, 2013 ; Brvar et al, 2018 ; Aman et al, 2021 ; Kumar et al, 2022 ).…”